Skip to main content
PARAGON CARE LIMITED logo

PARAGON CARE LIMITED — Investor Relations & Filings

Ticker · PGC ISIN · AU000000PGC4 LEI · 529900E2YER7JPV13S18 ASX Wholesale and retail trade
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2026-05-17 Share Issue/Capital Cha…
Country AU Australia
Listing ASX PGC

About PARAGON CARE LIMITED

https://paragoncare.com.au

Paragon Care Limited provides integrated healthcare solutions, specializing in the supply and service of medical equipment, devices, and consumables. The organization operates across multiple clinical segments, including acute care, aged care, primary care, and diagnostic services. Its extensive portfolio includes surgical instruments, patient monitoring systems, and diagnostic imaging technology. A core component of its business model is the provision of comprehensive technical support, maintenance, and repair services through a specialized service division. By establishing strategic partnerships with global medical technology manufacturers, the company facilitates the delivery of advanced clinical solutions aimed at enhancing patient outcomes and optimizing operational efficiency for healthcare facilities.

Recent filings

Filing Released Lang Actions
Expiry of Voluntary Escrow Restrictions 1
Share Issue/Capital Change Classification · 85% confidence The document is an ASX announcement regarding the expiry of voluntary escrow restrictions on 943,524,072 ordinary shares, effective 3 June 2026. This relates to a change in the capital structure of the company (removal of escrow restrictions on existing shares), which falls under “Share Issue/Capital Change” (SHA). It is not a share buyback or insider transaction, nor a report publication. Therefore, SHA is the appropriate classification.
2026-05-17 English
Notification regarding unquoted securities - PGC 6 pages 18.5KB
Share Issue/Capital Change Classification · 83% confidence The document is an ASX Appendix 3G notice for the issue of unquoted equity securities (performance rights) under an employee incentive scheme, detailing the number of securities issued, dates, and related share capital information. This is an announcement of a share issue/capital change, not a financial report or general regulatory RNS. Therefore, it should be classified as Share Issue/Capital Change (SHA).
2026-05-12 English
ParagonCare completes Haju Medical acquisition 1 pa
M&A Activity Classification · 95% confidence The document is an ASX announcement dated 2 April 2026, stating that Paragon Care Limited has completed the acquisition of 100% of issued shares in Haju Medical. The text is brief (1211 characters) and focuses on announcing the completion of an acquisition transaction. There are no financial statements, detailed financial analysis, or regulatory filings such as merger proxy statements. This fits the definition of an M&A Activity announcement, which covers announcements related to merger proposals or takeover bids. The document is not a full merger filing (MA), nor a report or presentation. Therefore, the appropriate classification is M&A Activity (TAR).
2026-04-01 English
Appointment of Managing Director 2 pages 237.8KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 25 February 2026 regarding the appointment of a new Managing Director, Carmen Riley, at Paragon Care Limited. It details the leadership succession plan, roles, and terms of employment. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to reports or meetings beyond the appointment announcement. The content focuses solely on management changes at the board/executive level. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4068 characters, which is consistent with a detailed announcement but not a full report or transcript.
2026-02-24 English
1H26 Appendix 4D and Half Year Report 37 pages 5.8MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Report FY26' and references the half-year ended 31 December 2025, indicating it is a report for a period shorter than a full fiscal year. It contains detailed financial data including revenues, net loss, EBITDA, segment contributions, and notes on accounting treatments. It also includes a Directors' Report and mentions an auditor's review report attached as part of the Interim Report. The presence of comprehensive financial statements and analysis for the half-year period aligns with the definition of an Interim / Quarterly Report (IR). The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-02-24 English
1H26 Results Release 6 pages 518.7KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 25 February 2026 presenting the half-year financial results for the period ended 31 December 2025 (HY26). It contains detailed financial data including revenue, EBITDA, NPAT, segment revenue breakdown, expenses, capital management, integration updates, and outlook for the full fiscal year 2026. The document is comprehensive and includes substantive financial statements and analysis for a period shorter than a full fiscal year, which fits the definition of an Interim / Quarterly Report (IR). It is not merely an announcement of a report or a certification, but a full financial results disclosure for the half-year period. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-02-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.